PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2
Clinical trial NCT05011396 · TERMINATED
Trial details
- NCT number
- NCT05011396
- Sponsor
- VistaGen Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-30
- Primary completion
- 2022-08-16
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.